Akums gets EU-GMP certification for two Haridwar plants

Regulatory Product ApprovalBusiness Updates View source PDF Explain this filing

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹424.00

prior close

₹433.60

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.1%+1.7% vs market

Pharmaceuticals peers, median of 154sector-0.4%+2.2% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.7

10m

-2.0

15m

-2.0

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+0.1+1.7-0.4+2.2

Next day

+1.8+2.2-0.4+0.0+1.7

+3.1+1.8+1.3-0.7+3.8

+3.8+3.6+0.2+0.0+3.8

+3.8+2.3+1.5-0.2+4.0

+5.4+6.1-0.7+2.3+3.1

+5.0+6.4-1.5+1.9+3.0

15d

+15.6+7.0+8.6+1.9+13.7

+15.7+3.8+11.9-0.4+16.0

+11.6-5.2+16.8-8.1+19.7

+25.2+12.5+12.7+3.9+21.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akums Drugs received EU-GMP certificates from the Bulgarian Drug Agency for its Plant 1 and Plant 2 at Haridwar, Uttarakhand. Plant 1 is a renewal covering tablets, capsules and sachets; Plant 2 is a first-time certification covering oral liquid formulations. Both approvals are valid for 3 years till October 2028. The certification enables Akums to supply EU regulated markets and will support the European CDMO contract signed in December 2024.

Likely market impact

Opens EU regulated markets for Akums, supporting the existing European CDMO contract and unlocking new export opportunities in hard currency markets.